Stratification of clear cell renal cell carcinoma by signaling pathway analysis

被引:7
|
作者
Cremona, Mattia [1 ]
Espina, Virginia [2 ]
Caccia, Dario [1 ]
Veneroni, Silvia [1 ]
Colecchia, Maurizio [3 ]
Pierobon, Mariaelena [2 ]
Deng, Jianghong [2 ]
Mueller, Claudius [2 ]
Procopio, Giuseppe [4 ]
Lanzi, Cinzia [1 ]
Daidone, Maria Grazia [1 ]
Cho, William C. S. [5 ]
Petricoin, Emanuel F. [2 ]
Liotta, Lance [2 ]
Bongarzone, Italia [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy
[2] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA
[3] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[5] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
关键词
autophagy; HIF; hypoxia; mTOR; renal cell carcinoma; reverse-phase protein array; signaling pathway; GROWTH-FACTOR RECEPTOR; TARGETED THERAPY; CANCER; AUTOPHAGY; MTOR; EGFR; VHL; PHOSPHORYLATION; MICRODISSECTION; INACTIVATION;
D O I
10.1586/14789450.2014.893193
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Investigation of cell signaling pathways in 16 clear cell renal cell carcinomas to identify groups based on commonly shared phosphorylation-driven signaling networks. Using laser capture microdissection and reverse-phase protein arrays, we profiled 75 key nodes spanning signaling pathways important in tumorigenesis. Analysis revealed significantly different (P < 0.05) signaling levels for 27 nodes between two groups of samples, designated A (4 samples; high EGFR, RET, and RASGFR1 levels, converging to activate AKT/mTOR) and B (12 samples; high ERK1/2 and STAT phosphorylation). Group B was further partitioned into groups C (7 samples; elevated expression of LC3B) and D (5 samples; activation of Src and STAT). Network analysis indicated that group A was characterized by signaling pathways related to cell cycle and proliferation, and group B by pathways related to cell death and survival. Homogeneous clear cell renal cell carcinomas could be stratified into at least two major functional groups.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [41] Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
    Culliford, Richard
    Lawrence, Samuel E. D.
    Mills, Charlie
    Tippu, Zayd
    Chubb, Daniel
    Cornish, Alex J.
    Browning, Lisa
    Kinnersley, Ben
    Bentham, Robert
    Sud, Amit
    Pallikonda, Husayn
    Frangou, Anna
    Gruber, Andreas J.
    Litchfield, Kevin
    Wedge, David
    Larkin, James
    Turajlic, Samra
    Houlston, Richard S.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [42] Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations
    Grimm, Julia
    Zeuschner, Philip
    Janssen, Martin
    Wagenpfeil, Stefan
    Hartmann, Arndt
    Stoehr, Christine
    Keck, Bastian
    Kahlmeyer, Andreas
    Stoeckle, Michael
    Junker, Kerstin
    GENES CHROMOSOMES & CANCER, 2019, 58 (09): : 612 - 618
  • [43] Clear Cell Papillary Renal Cell Carcinoma (CCPAP): A Distinct Entity or a Variant of Clear Cell Renal Cell Carcinoma?
    Rohan, S. M.
    Dudas, M. E.
    Gopalan, A.
    Fine, S. W.
    Reuter, V. E.
    Tickoo, S. K.
    LABORATORY INVESTIGATION, 2009, 89 : 191A - 191A
  • [44] Clear Cell Papillary Renal Cell Carcinoma (CCPAP): A Distinct Entity or a Variant of Clear Cell Renal Cell Carcinoma?
    Rohan, S. M.
    Dudas, M. E.
    Gopalan, A.
    Fine, S. W.
    Reuter, V. E.
    Tickoo, S. K.
    MODERN PATHOLOGY, 2009, 22 : 191A - 191A
  • [45] The application of single cell analysis to understand clear cell renal cell carcinoma
    Willsher, A. R.
    Foxall, R. B.
    Ashton-Key, M.
    Smith, R. C.
    Thirdborough, S.
    Lim, S. H.
    Beers, S. A.
    Cragg, M.
    JOURNAL OF PATHOLOGY, 2023, 261 : S18 - S18
  • [46] Clear cell papillary renal cell carcinoma: A new distinct entity or subtype of clear cell renal carcinoma
    Deml, K. -F.
    Schildhaus, H. -U.
    Comperat, E.
    Schraml, P.
    Storz, M.
    von Teichmann, A.
    Bonventre, J.
    Moch, H.
    VIRCHOWS ARCHIV, 2014, 465 : S5 - S5
  • [47] Cell heterogeneity in clear cell renal cell carcinoma
    Lopez, Jose I.
    Guarch, Rosa
    Larrinaga, Gorka
    Corominas-Cishek, Alexandra
    Orozco, Roberto
    APMIS, 2013, 121 (12) : 1187 - 1191
  • [48] Misdiagnosis of clear cell renal cell carcinoma
    Vladimir A. Valera
    Maria J. Merino
    Nature Reviews Urology, 2011, 8 : 321 - 333
  • [49] Biomarkers in clear cell renal cell carcinoma
    George, Saby
    Bukowski, Ronald M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1737 - 1747
  • [50] Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
    Zhang, Ning
    Chen, Wenxin
    Gan, Zhilu
    Abudurexiti, Alimujiang
    Hu, Xiaogang
    Sang, Wei
    MEDICINE, 2020, 99 (21) : E20470